Clinical Trials Directory

Trials / Completed

CompletedNCT07318766

Incentive Spirometer in Liver Transplant Recipients

Effect of Incentive Spirometer on Arterial Blood Gases in Liver Transplant Recipients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study evaluated the effect of adjunctive incentive spirometer on arterial blood gases (ABGs) and early postoperative recovery in liver transplant recipients.

Detailed description

In this prospective , randomized study, 40 adults undergoing living-donor liver transplantation (LT) were assigned to standard post-transplant mobilization and breathing exercises alone (n=20) or standard exercises plus structured IS training (n=20). Arterial blood gases ABG parameters (pH, PO₂, PCO₂, HCO₃-, SpO₂) were measured at baseline and on postoperative days 1-3. Linear mixed-effects models assessed group differences in ABG trajectories; slope analyses quantified decline and recovery phases. Secondary outcomes included intensive care unit (ICU) and hospital length of stay (LOS) and Post-operative pulmonary complications incidence.

Conditions

Interventions

TypeNameDescription
DEVICEIncentive SpirometryAn intensive spirometry (IS) is a device that measures inhaled air volume and provides visual feedback as a piston rises during inspiration. It is widely used in respiratory and physical therapy to encourage slow, deep breathing, which helps expand the lungs, open airways, and mimic the natural deep breaths seen in yawning or sighing.

Timeline

Start date
2024-11-01
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2026-01-06
Last updated
2026-01-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07318766. Inclusion in this directory is not an endorsement.